NF-κB1 expression was classified as ‘low’ (<33% positive carcinoma cells), ‘intermediate’ (≥33 and <66% positive carcinoma cells) or ‘high’ (≥66% positive carcinoma cells). The gene discussed is NFKB1; the disease is carcinoma.